In a study of nearly 6,000 patients with chronic kidney disease and heart failure, the use of implantable cardioverter defibrillators (ICDs) was associated with a significantly increased risk of subsequent hospitalization.

Dr. Nisha Bansal and Dr. Alan Go
Researchers Nisha Bansal of the Kidney Research Institute and Alan Go of Kaiser Permanente led the study.

Researchers at the University of Washington School of Medicine and Kaiser Permanente conducted the study, which was published in JAMA Internal Medicine.

“The finding surprised us,” said lead author Dr. Nisha Bansal, a UW Medicine nephrologist with the Kidney Research Institute. “Chronic kidney disease is common in adults with heart failure, and is associated with a greater risk of heart attack. However, in this observational study we did not find a significant benefit from ICDs for patients with kidney disease.”

To learn more about the study, including a podcast interview with Dr. Bansal, check out these links:

JAMA Internal Medicine Publication

JAMA Network Audio Podcast Interview with Dr. Bansal

UW Medicine Newsroom Article